Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Koehl

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Frontiers in Immunology|September 1, 2022
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapiesBarbara Seliger, Ulrike Koehl
Frontiers in Immunology|July 28, 2017
Natural Killer Cell-Based Cancer Immunotherapies: From Immune Evasion to Promising Targeted Cellular TherapiesErhard Hofer, Ulrike Koehl
Frontiers in Immunology|March 15, 2018
Editorial: Tailoring NK Cell Receptor-Ligand Interactions: An Art in EvolutionUlrike Koehl, Antoine Toubert, Gianfranco Pittari
Frontiers in Immunology|June 27, 2017
Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an "Off-the-Shelf Immunotherapy" for Improvement in Cancer TreatmentOlaf Oberschmidt, Stephan Kloess, Ulrike Koehl
Nature Biomedical Engineering|January 6, 2026
Non-viral vectors as beacons of hope for reducing genotoxic risks of gene therapyMarie-Madeleine Nzila, Ulrike Koehl, Zoltán Ivics
Medical Mycology|July 25, 2008
Cultivated anti-Aspergillus T(H)1 cellsThomas Lehrnbecher, Olaf Beck, Ulrike Koehl, et al.
Cancers|July 10, 2020
Harnessing NK Cell Checkpoint-Modulating ImmunotherapiesSachin Kumar Singh Chauhan, Ulrike Koehl, Stephan Kloess
Frontiers in Immunology|August 10, 2017
Influence of Irradiated Peripheral Blood Mononuclear Cells on Both <i>Ex Vivo</i> Proliferation of Human Natural Killer Cells and Change in Cellular PropertyMaría Delso-Vallejo, Jutta Kollet, Ulrike Koehl, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 28, 2019
CAR-Expressing Natural Killer Cells for Cancer RetargetingStephan Kloess, Anna Kretschmer, Lilly Stahl, et al.
Biomedicines|February 25, 2022
CD14 Is Involved in the Interferon Response of Human Macrophages to Rubella Virus InfectionErik Schilling, Lukas Pfeiffer, Sunna Hauschildt, et al.
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Frontiers in Immunology|September 1, 2022
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapiesBarbara Seliger, Ulrike Koehl
Frontiers in Immunology|July 28, 2017
Natural Killer Cell-Based Cancer Immunotherapies: From Immune Evasion to Promising Targeted Cellular TherapiesErhard Hofer, Ulrike Koehl
Frontiers in Immunology|March 15, 2018
Editorial: Tailoring NK Cell Receptor-Ligand Interactions: An Art in EvolutionUlrike Koehl, Antoine Toubert, Gianfranco Pittari
Frontiers in Immunology|June 27, 2017
Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an "Off-the-Shelf Immunotherapy" for Improvement in Cancer TreatmentOlaf Oberschmidt, Stephan Kloess, Ulrike Koehl
Nature Biomedical Engineering|January 6, 2026
Non-viral vectors as beacons of hope for reducing genotoxic risks of gene therapyMarie-Madeleine Nzila, Ulrike Koehl, Zoltán Ivics
Medical Mycology|July 25, 2008
Cultivated anti-Aspergillus T(H)1 cellsThomas Lehrnbecher, Olaf Beck, Ulrike Koehl, et al.
Cancers|July 10, 2020
Harnessing NK Cell Checkpoint-Modulating ImmunotherapiesSachin Kumar Singh Chauhan, Ulrike Koehl, Stephan Kloess
Frontiers in Immunology|August 10, 2017
Influence of Irradiated Peripheral Blood Mononuclear Cells on Both <i>Ex Vivo</i> Proliferation of Human Natural Killer Cells and Change in Cellular PropertyMaría Delso-Vallejo, Jutta Kollet, Ulrike Koehl, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 28, 2019
CAR-Expressing Natural Killer Cells for Cancer RetargetingStephan Kloess, Anna Kretschmer, Lilly Stahl, et al.
Biomedicines|February 25, 2022
CD14 Is Involved in the Interferon Response of Human Macrophages to Rubella Virus InfectionErik Schilling, Lukas Pfeiffer, Sunna Hauschildt, et al.
Pageof 12